Novartis Starts Phase II Trial for Copy of Roche's Rituxan

11.01.2011 - Novartis advanced its bid to copies Roche's multi-billion dollar antibody drug rituximab on Monday, starting phase II trials for its own version of the blockbuster medicine. Drugs...